![Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1735-4/MediaObjects/13075_2018_1735_Fig2_HTML.png)
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text
![Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1867-1/MediaObjects/13075_2019_1867_Fig1_HTML.png)
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text
![Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/78/9/1242/F2.large.jpg)
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases
![Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors](https://www.frontiersin.org/files/Articles/433394/fimmu-09-03112-HTML/image_m/fimmu-09-03112-g001.jpg)
Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
![Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/c9c7df46-c8c1-469b-83d6-30e2cbd739d6/gr1.jpg)
Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials - The Lancet Rheumatology
![Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-018-1735-4/MediaObjects/13075_2018_1735_Fig1_HTML.png)
Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China | Arthritis Research & Therapy | Full Text
![Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-021-02672-y/MediaObjects/13075_2021_2672_Fig3_HTML.png)
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text
![Biomedicines | Free Full-Text | Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis Biomedicines | Free Full-Text | Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis](https://www.mdpi.com/biomedicines/biomedicines-10-00316/article_deploy/html/images/biomedicines-10-00316-g001.png)
Biomedicines | Free Full-Text | Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis
![Kaplan-Meier survival curves for systemic sclerosis (SSc) patients from... | Download Scientific Diagram Kaplan-Meier survival curves for systemic sclerosis (SSc) patients from... | Download Scientific Diagram](https://www.researchgate.net/publication/283323487/figure/fig1/AS:560906811985921@1510742013895/Kaplan-Meier-survival-curves-for-systemic-sclerosis-SSc-patients-from-disease-onset.png)
Kaplan-Meier survival curves for systemic sclerosis (SSc) patients from... | Download Scientific Diagram
![Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-021-02672-y/MediaObjects/13075_2021_2672_Fig2_HTML.png)
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality | Arthritis Research & Therapy | Full Text
![Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1867-1/MediaObjects/13075_2019_1867_Fig2_HTML.png)
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature | Arthritis Research & Therapy | Full Text
![Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-2140-3/MediaObjects/13075_2020_2140_Fig1_HTML.png)
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort | Arthritis Research & Therapy | Full Text
![The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients - ACR Meeting Abstracts The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2014/08/Paper-36139-abstract-43320-0.png)